bluebird bio announces proposed public offering of common stock
bluebird bio announced it has commenced an underwritten public offering of $600 million of its common stock. bluebird bio intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent of the shares of common stock offered in the public offering. December 11, 2017